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Human serum potently induces hyphal development
of the polymorphic fungal pathogen Candida albi-
cans, a phenotype that contributes critically to infec-
tions. The fungal adenylyl cyclase Cyr1p is a key
component of the cAMP/PKA-signaling pathway
that controls diverse infection-related traits, includ-
ing hyphal morphogenesis. However, identity of the
serum hyphal inducer(s) and its fungal sensor remain
unknown. Our initial analyses of active serum frac-
tions revealed signs of bacterial peptidoglycan
(PGN)-like molecules. Here, we show that several
purified and synthetic muramyl dipeptides (MDPs),
subunits of PGN, can strongly promote C. albicans
hyphal growth. Analogous to PGN recognition by
the mammalian sensors Nod1 and Nod2 through
their leucine-rich-repeat (LRR) domain, we show
that MDPs activate Cyr1p by directly binding to its
LRR domain. Given the abundance of PGN in the
intestine, a natural habitat and invasion site for
C. albicans, our findings have important implications
for the mechanisms of infection by this pathogen.
INTRODUCTION
Due to the AIDSpandemic,C. albicans has evolved froma largely
harmless commensal to the most prevalent fungal pathogen in
humans (Odds, 1985; Calderone and Fonzi, 2001; Gow et al.,
2002; Klepser, 2006). C. albicans often causes life-threatening
systemic infections in immunocompromised patients. A remark-
able trait of this fungus is its ability to switch between several
growth forms such as budding yeast, pseudohyphae, and
true hyphae in response to environmental cues (Berman and
Sudbery, 2002). The yeast-to-hypha transition facilitates tissue
penetration and avoidance of phagocytic destruction in the
host (Cutler, 1991; Lo et al., 1997; Phan et al., 2000). C. albicans
mutants defective in this growth transition exhibit greatly
reduced virulence (Lo et al., 1997; Stoldt et al., 1997; Zheng
et al., 2004). Therefore, blocking the growth switch is widely
thought to be a potential strategy for developing new therapies28 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.for candidiasis. Although a wide range of chemicals and growth
conditions can trigger C. albicans hyphal growth, serum is indis-
putably themost potent and physiologically relevant (Gow, 1997;
Ernst, 2000). However, the identity of the inducer(s) and that of its
sensor in C. albicans remain poorly defined.
Feng et al. (1999) first found that most of the serum hypha-
inducing activity can pass through a dialysis membrane with
a molecular weight cutoff of 1 kDa. Hudson et al. (2004) sug-
gested that glucose is responsible for80%of theserumactivity.
However, given the fact that hyphal induction is routinely per-
formed in laboratories byusing5%–20%serum inmedia contain-
ing glucose at concentrations 10- to 20-fold higher than those
found in normal serum, it cannot account for the serum activity.
A central signaling cascade for hyphal growth is the cAMP/
protein kinase A (PKA) pathway (Leberer et al., 2001; Rocha
et al., 2001; Liu, 2002). C. albicans has a single adenylyl cyclase
Cyr1p. Hyphal induction activates this enzyme, increasing intra-
cellular cAMP levels, which subsequently activates PKA (Bahn
and Sundstrom, 2001; Rocha et al., 2001). This pathway triggers
the expression of hypha-specific genes involved in diverse infec-
tion-related functions including hyphal growth (Ernst, 2000; Lane
et al., 2001; Liu, 2002; Zheng et al., 2004). CYR1 deletion com-
pletely abolishes hyphal development and severely retards yeast
growth (Rocha et al., 2001). Recent studies suggest that Cyr1p
may be involved directly in signal sensing. Klengel et al. (2005)
reported that the catalytic domain of Cyr1p acts as a CO2 sensor
and thus mediates CO2-induced filamentous growth. A sensory
role of Cyr1p was also suggested for quorum-sensing molecules
(Hogan et al., 2004; Davis-Hanna et al., 2008). However, the mo-
lecular details of signal sensing and the ensuing cyclase activa-
tion remain to be elucidated. In addition to the cyclase domain,
Cyr1p contains two other conserved domains: an N-terminal
RAS-association (RA) domain and a middle domain composed
of 14 leucine-rich repeats (LRRs). Long-LRR domain is a key fea-
ture of several protein families involved in innate immunities in
mammals, insects, and plants that recognize distinct patho-
gen-associated molecular patterns (PAMPs), such as peptido-
glycans (PGNs), lipopolysaccharides, and lipoproteins (Inohara
and Nun˜ez, 2003a; Philpott and Girardin, 2004). Substantial evi-
dence suggests that LRR domains have a direct role in ligand
sensing. Particularly relevant to this work are two mammalian
bacterial sensors Nod1 and Nod2 that use their LRR domain
to recognize PGN fragments with a minimal structure of
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glutamine, respectively (Girardinetal., 2003b; Inoharaetal., 2003b).
In this study, we have attempted to identify and characterize
the hypha inducers in serum and their sensor in C. albicans.
We detected PGN-like molecules in chromatographic fractions
of serum enriched for hypha-inducing activities. By purification
and chemical synthesis, we found that several PGN motifs ex-
hibited exceedingly potent hypha-inducing activities. We also
provide compelling evidence that PGN-derived molecules can
directly bind to the LRR domain of Cyr1p, stimulate cAMP pro-
duction, and promote hyphal growth. Our findings have identi-
fied a potentially important host-associated virulence factor
and its sensor in the pathogen.
RESULTS
Detection of PGN-like Molecules in Serum Fractions
Active for Hyphal Induction
To identify thehyphal inducer(s) in serum,weperformedaseriesof
chromatographic fractionations of human plasma and bovine se-
rum filtrates and tracked the inducing activity by treating 53 105
yeast cells/ml at 37C in Hank’s buffered salt solution (HBSS)
(Figure1A), a conditionempirically found toallow low-background
hyphal growth (Fang and Wang, 2006). Our studies on human
plasma and bovine serum yielded similar results. In the last purifi-
cation step using reversed-phase high performance liquid chro-
matography (HPLC), high activities were eluted between 9 and
14 min (Figure 1B). When pooled, this sample (F9-14) induced
>90% hyphal growth at concentrations of 0.1 mg dry material
per ml compared with1.5 mg/ml of the starting filtrates for sim-
ilar levels of induction. However, further resolution of the active
components proved difficult because the activity was always dis-
tributedbroadly.We thensubjectedF9-14 toNMRanalysis,which
revealedconsiderableamountsofglucose, fructose,glycerol, and
lactic acid (data not shown). However, thesemolecules exhibited
no significant hypha-inducing activity singly or in combination.
The NMR data also suggested structures resembling muramic
acid (Mur), alanine (Ala), and isoglutamine (iGln). Mur is a hallmark
of bacterial PGN innature, and iGln is a commonaminoacid found
in the oligopeptides that crosslink the glycan strands (Shockman
and Barrett, 1983; Cloud-Hansen et al., 2006). We thus proposed
a structure Mur-L-Ala-D-iGln (MAiGn) based on the highly
conserved PGN subunit MurNAc-L-Ala-D-iGln (MNAiGn)
(Figure 1C). In this paper, these two molecules and their deriva-
tives are collectively referred to asMDPs for muramyl dipeptides.
Later, comparisons of the NMR data of F9-14 with that of pure
MAiGn supported this proposal (see below and Tables S1 and
S2). MDPs are well-known signaling molecules that can trigger
a range of physiological responses inmammals andmediate bac-
terial interactions with diverse organisms (Johannsen et al., 1990;
Koropatnick et al., 2004; Cloud-Hansen et al., 2006).
Purified and Synthetic MDPs Exhibit Strong
Hypha-Inducing Activity
Next we obtained PGNs from theGram-negative Escherichia coli
and the Gram-positive Staphylococcus aureus to test whether
they can induce C. albicans hyphal growth. While polymeric
PGNs at concentrations up to 10 mg/ml exhibited no such activ-
ity, their partial hydrolysis with HCl producedmolecules (filtrate <3 kDa) that induced >90% true hyphae at concentrations as low
as15mg/ml (Figure 1D). In contrast, the hydrolysis products >3 kDa
were not active at concentrations up to 10 mg/ml (data not
shown). The results suggest that certain PGN-derived molecules
are potent inducers for C. albicans hyphal growth. However, due
to the exceedingly high complexity of the PGN lysates, it was
difficult to identify and purify individual activemolecules. Alterna-
tively, we synthesized MAiGn (see Supplemental Data). Strik-
ingly, this compoundexhibiteda strong, concentration-dependent
activity, causing 50% (I50) of true hyphae at 15 and 31 mM
in glucose minimal medium (GMM) and HBSS, respectively
(Figure 2A). Furthermore, MNAiGn (commercially available) was
also active but with an I50 of 3–4 mM. N-acetylglucosamine
(GlcNAc), another conserved PGN component long known to
be a strong hyphal inducer (Simonetti et al., 1974) had an I50
of 1.8 mM. Mur, L-Ala, and D-Glu at concentrations up to
10 mM are not active for hyphal induction either individually or
when mixed at equal molar concentrations (data not shown).
In search of an economical way to obtainMAiGn,we found that
treating MNAiGn (m/z = 493 Da as M + 1 in mass spectrometry
[MS]) with 1N HCl at room temperature for 16–20 hr could gener-
ate hydrolysates that cause hyphal growth at nanomolar concen-
trations in both liquid and solid media (Figures 2A and 2B). Liquid
chromatography (LC)/MS analyses of the lysates revealed two
major products with m/z of 452 and 494 Da, corresponding
to Mur-L-Ala-D-Glu and MurNAc-L-Ala-D-Glu, respectively
(Figure S1). Among many minor hydrolysis products, one 476
Da ion was identified to be 1,6-anhydro-Mur-L-Ala-D-Glu (see
Supplemental Data). We purified and tested these three com-
pounds for hyphal induction. Figure 2A shows that 1,6-anhy-
dro-Mur-L-Ala-D-Glu, Mur-L-Ala-D-Glu, and MurNAc-L-Ala-D-
Glu exhibited I50s of 2.3, 5.8, and 32.3 mM in HBSS, respectively.
These compounds were also active in GMM with somewhat dif-
ferent I50s. However, none of them was more active than the
crude lysates, suggesting that either the lysates contain uniden-
tified, more active compounds or that multiple compounds act
synergistically. Mixing the purified compounds in various ratios
never resulted in activities higher than the most active individual
component (data not shown). Currently, we cannot distinguish
between the two possibilities because of the great difficulty
and cost to obtain sufficient amounts of most of theminor hydro-
lysis products. Nonetheless, our data strongly support the con-
clusion that certain PGN-derived molecules are potent inducers
for C. albicans hyphal growth.
Confirmation of Mur-Containing Compounds in Serum
Previous studies suggested that PGNs can enter the blood
stream through the intestinal epithelium (Sartor et al., 1987,
1988). Strong evidence for the presence of PGN-derived mole-
cules in blood came from the isolation from human urine of the
tracheal cytotoxin, a monomeric unit of PGN produced by cer-
tain Gram-negative bacteria (Krueger et al., 1982; Martin et al.,
1984; Cloud-Hansen et al., 2006). To confirm the presence of
PGN-derived molecules in serum, we did the following. Serum
filtrates were hydrolyzed with HCl to release Mur and then
treated with sodium borohydride to destroy by reduction the
anomeric center of the sugar ring, which splits chromatographic
peaks and thus complicates analysis (see Figure S1). The redu-
cedMur was thenmodified by adding a fluorescent dansyl groupCell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc. 29
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(A) ElutriatedG1 cells (SC5314, see Table S5 for all strains used) were incubated in HBSSwith or without 5% serum filtrate at 37C for 2 hr. The use of G1 cells was
to ensure uniform hyphal growth, allowing more accurate differentiation of the activities of various hypha-inducing compounds as described in later experiments.
Bars indicate 5 mm.
(B) The upper panel shows a chromatograph of reversed-phase HPLC separation of serum. To track the hypha-inducing activity, 10 ml of each fraction was added
to 40 ml of HBSS containing yeast cells at 5 3 105 cells/ml and then incubated at 37C for 2 hr (lower panel).
(C) A proposed compound (left) based on the NMR data (see Supplemental Data) and a subunit of typical bacterial PGN (right).
(D) E. coli and S. aureus PGNs were hydrolyzed with HCl, passed through a 3 kDa filter, and lyophilized before testing for hyphal induction in HBSS for 2 hr. Bar
indicates 5 mm.at the single NH2 group to facilitate detection byHPLC. Commer-
cial Mur processed in the same way was used as standard. After
dansylation, the samples were separated by HPLC and the frac-
tionmatching the retention time of the standardwas collected for
MS. Ions matching reduced dansyl Mur (m/z = 487.1 and 469.1
[ 1 H2O]) were detected in all five independent serum samples
tested (Figures 3A and 3B). These ions were undetectable if the
hydrolysis step was omitted (Figure 3C), suggesting that Mur in
serum is present as part of larger molecules. Further bombard-
ment of the 487.1 ion generated a subset of ions matching those
derived from the standard (Figure 4A). Thus, the results strongly
support the presence of Mur-containing compounds in serum.
Contamination of serum by PGNs during experiments is unlikely
because pure water processed using the same protocol did not
yield any of the characteristic ions (data not shown). To estimate
the amount of Mur in serum, we used sodium borodeuteride, in-
stead of sodium borohydride, to reduce standard Mur, which
increased themass of the reducedMur by 1 Da. Known amounts
of the heavier Mur were then added to serum filtrates that had
been hydrolyzedwith HCl and reducedwith sodiumborohydride.30 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.After dansylation, the samples were resolved by HPLC and the
fraction containing dansyl Mur was analyzed by MS (Figure 4B).
Comparing the relative intensities of 487.1 and 488.1 ions, the
concentration of Mur was estimated to be at least 0.1–0.5 mM in
the five serum samples tested. PGNs have also been detected
in various mammalian tissues in previous studies, although not
quantified (Sen and Karnovsky, 1984; Lehtonen et al., 1997;
Schrijver et al., 2001).
The LRR Domain of Cyr1p Is Required for C. albicans
Response to MDPs
PAMPs are recognized by pattern-recognition receptors (PRRs)
in diverse organisms (Royet and Dziarski, 2007). For example,
the mammalian innate immunity proteins Nod1 and Nod2 recog-
nize PGNmotifs (Girardin et al., 2003a, 2003b). PRRs commonly
contain a LRR domain for ligand binding (Philpott and Girardin,
2004; Royet and Dziarski, 2007). We speculated that C. albicans
might use a similar mechanism for MDP sensing. Using the LRR
sequences of Nod1 and Nod2 to search the C. albicans genome
database (www.candidagenome.org) scored a strong match
Cell Host & Microbe
Peptidoglycan Induces Candida albicans Hyphal GrowthFigure 2. Hypha-Inducing Activities of PGN-Derived Compounds
(A) SC5314 cells were induced for hyphal growth with different concentrations of the indicated compounds in liquid HBSS or GMM at 37C for 2 hr. Then, hyphal
cells were counted to draw the activity curves (the results of induction in GMMare not shown). The table shows the I50s for all the compounds tested in both HBSS
and GMM.
(B) MNAiGn was treated with 1 N HCl overnight at 22C and the hydrolysate was tested for hyphal induction in both liquid and solid HBSS media at the indicated
concentrations. SC5314 yeast cells were induced at 37C for 2 hr in liquid and 24 hr on plates. Bar indicates 5 mm.with the adenylyl cyclase Cyr1p that contains 14 LRRs organized
in three clusters from amino acid (aa) 489 to 898 (Figure 5A). To
determine whether the LRR domain is required for MDP sensing,
we first created a series of mutant versions of Cyr1p deleted for
either the entire LRR domain (cyr1-lrrD) or one of the LRR clus-
ters (cyr1-c1D, cyr1-cl2D, and cyr1-cl3D). We also created two
mutants in each of which two highly conserved residues in a sin-
gle repeat in the middle of clusters 1 and 2 were replaced with
Ala: they are cyr1-2AA and cyr1-9AA, carrying Leu/ Ala and
Asn / Ala mutations in repeats 2 and 9, respectively
(Figure 5A). The genomic DNA fragment containing the entire
CYR1 coding sequence and 50- and 30-flanking regions was
cloned in the plasmid CIp10 (Murad et al., 2000) as template
for mutagenesis. Each construct was linearized at a unique
MluI site within the promoter and transformed into the cyr1Dmu-
tant for integration at the chromosomal CYR1 promoter. Correct
synthesis of the proteins was verified by western blotting using
a mouse antiserum raised against the PP2C domain (Figure 5B).
The wild-typeCYR1 fully restored hyphal growth in cyr1D and re-
duced the doubling time of yeast growth from 4.46 hr to 1.67 hr
(Figure 5C). In contrast, none of the domain-deletion mutants
significantly restored hyphal growth (data not shown), althoughthey reduced the yeast doubling time to 2 hr. Moreover, the
cyr1-2AA and cyr1-9AA alleles could also restore the yeast
growth without significantly improving hyphal growth. The data
thus indicate that the LRR domain is essential for hyphal growth.
The LRR Domain of Cyr1p Directly Binds MDPs
Next we asked whether MDPs can bind to the LRR domain of
Cyr1p. We biotinylated (Bt) MNAiGn at the single COOH group
of iGln and then bound Bt-MNAiGn to streptavidin agarose
beads. The beads were incubated with the LRR domain of
Cyr1p (aa 480–900) that was expressed in E. coli and purified
as a GST fusion protein (GST-LRR), and for control, the same re-
gion containing the 9AA mutation (GST-9AA) was similarly pre-
pared (Figure 5D). The GST-LRR proteins bound to the beads
were detected by anti-GSTwestern blotting.With equal amounts
of the input proteins, the beads carrying Bt-MNAiGn pulled down
10 timesmore ofGST-LRR thanGST-9AA (Figure 5E). As a con-
trol, streptavidin beads without bound Bt-MNAiGn did not pull
down any GST-LRR. To gain more robust results, we tested
whether preincubating GST-LRR with MNAiGn or MAiGn can
block the pull-down. We preincubated GST-LRR with different
amounts of the two compounds for 60 min before adding theCell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc. 31
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in supernatants (unbound) were probed by western blotting. We
found that both MNAiGn and MAiGn blocked the pull-down in
concentration-dependent fashions (Figure 5F). Strikingly, MAiGn
is much more effective than MNAiGn, consistent with the ob-
served large difference between the two compounds in hypha-
inducing activities shown in Figure 2A.We further tested whether
Figure 3. Detection of Mur-Containing Compounds in Serum
(A–C) Both standard Mur (A) and Mur released from PGN in serum by HCl hy-
drolysis (B) were first reduced with borohydride and then dansylated before
HPLC separation. The serum fraction that matched the retention time of the
modified standard Mur was collected for MS. For negative controls (C), serum
was dansylated without prior HCl hydrolysis.32 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.MDPs can bind to Cyr1p in cell lysates. We constructed a
C. albicans strain expressing a version of Cyr1p with an N-termi-
nal HFM tag (His-Flag-Myc) (Sinha et al., 2007) under the control
of the MET3 promoter. Cell lysates from this strain were mixed
with the streptoavidin beads with or without bound Bt-MNAiGn.
HFM-Cyr1p was then detected by anti-Myc western blotting.
Figure 5G shows that the beads with bound Bt-MNAiGn pulled
down from the HFM-Cyr1p-containing lysate an 200 kDa pro-
tein that matches the predicted size of HFM-Cyr1p. This interac-
tion was blocked by preincubating the lysates with MAiGn.
Furthermore, this band was not detected in lysates of cells ex-
pressing Cyr1p without the HFM tag (data not shown). Together,
the data demonstrate direct interactions of MDPs with the LRR
domain of Cyr1p, strongly supporting our hypothesis that the
LRR domain serves as a sensor for MDPs.
Cellular MDP Uptake
Like Nod1 and Nod2, Cyr1p is an intracellular protein. Thus,
MDPs must enter the cell to bind to the cyclase. To test this,
we synthesized 3H-MNAiGn for an uptake assay. We grew
wild-type C. albicans in media containing different concentra-
tions of 3H-MNAiGn for 30 min and quantified 3H in cells by liquid
scintillation counting. This assay revealed concentration-depen-
dent 3H accumulations in cells (Figure 5H). Then,we repeated the
assay using a fixed concentration of 3H-MNAiGn (200 mM) and
quantified the uptake over time. The results showed a time-
dependent increase in intracellular 3H (Figure 5I). Together, the
data support the idea that MDP can enter the cell. However, it re-
mains possible that 3H enters the cell after the breakdown of
3H-MNAiGn. To address this, we used MS to determine whether
intact MNAiGn molecules can be detected in lysates of cells
grown in the presence of MNAiGn at 30C for 30 min. Duplicate
cultures were kept on ice for 30 min as negative controls. Cells
were washed extensively before lysis in the presence of 0.04%
TFA (to reduce binding of MDP to proteins). The lysates were
filtered to remove proteins before HPLC separation. Fractions
corresponding to the control MNAiGn were collected for MS
analysis. Ions with m/z of 493.2 and 475.2, matching MNAiGn
and MNAiGn 1 H2O respectively, were detected only in cells
cultured at 30C but not in those kept on ice (Figure S2), indicat-
ing that intact MNAiGn molecules can enter the cell. Although
C. albicans can take up MDPs, the compounds cannot support
cell growthas thesolecarbonornitrogensource inmedia (FigureS3).
Recent reports suggested that the intestinal apical di/tripep-
tide transporter, hPepT1, may be responsible for MNAiGn up-
take (Vavricka et al., 2004; Ismair et al., 2006). C. albicans
contains two hPepT1 homologs encoded by orf19.6937 and
orf19.2583. However, our unpublished data showed that mu-
tants deleted of both genes were normal in both 3H-MNAiGn up-
take and hyphal growth. Another possible candidate for MDP
transporter is the GlcNAc transporter NGT1 found in C. albicans
by Alvarez and Konopka (2007). But gene deletion had no signif-
icant effect on 3H-MNAiGn uptake and hyphal growth either
(data not shown). Thus, the mechanism for MDP uptake in
C. albicans remains to be elucidated.
MDPs Activate the Cyclase Activity of Cyr1p
When C. albicans yeast cells are exposed to hyphal induction,
intracellular cAMP levels rise transiently (Leberer et al., 2001;
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(A) The 487.18 ions detected from standard Mur and serum in the MS results shown in Figure 3B were further fragmented in the second round of MS. The pro-
posed structures of the common ions (a–f) are shown.
(B) Mur in serum was reduced with sodium borohydride. Then the sample was spiked with known amounts of standard Mur that had been reduced with boro-
deuteride (D-Mur). Dansylation, HPLC, andMSwere then done as described in Figure 3. The result is representative of serum samples from five healthy people of
25–30 years of age.Rocha et al., 2001). We next asked whether the LRR domain is
required for cAMP production. While cyr1D cells could not pro-
duce cAMP, reintroducing a copy of cyr1-lrrD or cyr1-9AA re-
stored the cAMP level to 1.2–1.6 pmol per mg of dried cells
compared to 1.8 pmol for wild-type (Figure 6A). In response
to hyphal induction, wild-type cells increased the cAMP level
to 3.8 pmol after 20–30 min. In contrast, cells expressing
Cyr1p-lrrD or Cyr1p-9AA exhibited only a slight increase, indi-
cating that the LRR domain is critically required for raising cel-
lular cAMP levels upon hyphal induction. To further confirm
that MAiGn enhances the adenylyl cyclase activity, we mea-
sured the conversion of a-32P-ATP to 32P-cAMP in mecha-
nically disrupted cells in the presence of different amounts
of MAiGn. We found that 5 mM of the compound was suffi-
cient to maximally activate the production of 32P-cAMP in dis-
rupted wild-type cells (Figure 6B), whereas no activation was
observed in disrupted cyr1D or cyr1-9AA cells (Figure 6C).
The results are consistent with the idea that the MDP-LRR in-
teraction directly enhances the adenylyl cyclase activity of
Cyr1p.Synergistic Effects of MDPs and CO2
Previous studies showed that bicarbonate, the hydrated form of
CO2, can activate the recombinant catalytic domain of Cyr1p by
>20-fold in vitro, presumably responsible for the CO2-induced
filamentous growth (Klengel et al., 2005). Next, we wished to
know whether CO2 may act synergically with MDPs. First, we
compared hyphal growth induced with different concentrations
of MDPs either in the atmospheric air or in 5% CO2. Figure 7A
shows that hyphal growth was markedly stronger in the pres-
ence of CO2. For example, 5% CO2 or 20 mM MAiGn alone
caused little hyphal growth after 3 hr of induction, whereas com-
bining the two resulted in >80%of true hyphal growth, consistent
with a synergistic effect. Similar synergy was also observed be-
tween 5% CO2 and 0.5–5 mM MNAiGn (data not shown).
Although 5–20 mM bicarbonate could also induce strong hyphal
growth, the synergy with MDPs was not obvious (data not
shown). Next, we wanted to determine whether bicarbonate
and MDPs have any synergistic effects on cellular cAMP levels
and the activity of Cyr1p. We found that induction with 10 mM
bicarbonate produced a spike in cAMP cellular levels, whichCell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc. 33
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(A) Cyr1p domain organization. RA, Ras-association domain; PP2C, protein phosphatase 2C domain; andCYCc, catalytic domain. The LRR consensus sequence
is shown, and the two residues selected for mutation to Ala are underlined.
(B) Western blot verification of the expression of various CYR1 alleles.
(C) Doubling times of the strains used in (B) in GMM at 30C.
(D) SDS-PAGE of purified GST-LRR and GST-9AA. The gel was stained with Coomassie blue.
(E) Ten micrograms of GST-LRR or GST-9AA were incubated with streptavidin beads with or without bound Bt-MNAiGn at 4C overnight. After washes, proteins
bound to the beads were resolved by SDS-PAGE and then probed by anti-GST western blotting.
(F) Purified GST-LRR was mixed with different amounts of MNAiGn or MAiGn at 4C for 60 min before adding the streptoavidin beads with bound Bt-MNAiGn.
After overnight incubation at 4C, the beads were precipitated by centrifugation. Then, GST-LRR both on beads (bound) and in supernatants (unbound) was
detected by anti-GST western blotting.
(G) Cell lysates containing HFM-Cyr1p with or without preincubation with MAiGn were incubated with streptavidin beads with or without bound Bt-MNAiGn as
described in (F). HFM-Cyr1p was probed with the Myc antibody.
(H) 3H-MNAiGn uptake. Aliquots of 13 108/ml yeast cells were incubated in 2ml HBSS containing different concentrations of 3H-MNAiGn at 37C for 30min. 3H in
cells was quantified by scintillation counting. Duplicate cultures were kept on ice for assessing nonspecific 3H binding to cells. Standard errors are shown, which
were calculated from results of three independent experiments throughout the paper.
(I) Aliquots of 1 3 108/ml yeast cells were incubated in 2 ml HBSS containing 200 mM 3H-MNAiGn at 37C for the indicated times before scintillation counting.peaked at15 min compared to30 min under serum induction
(Figure 7B). However, the peak levels detected were similar
under the two conditions. Induction with both bicarbonate and
serum delayed the peak to 45 min without significant effects
on the peak level of cAMP. We did not examine the effect of
MDPs on cellular cAMP levels due to the inhibitive cost of the34 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.large amounts of the compounds required for such experiments.
Alternatively, we performed the adenylyl cyclase activity assay
using cell lysates as described in Figures 6B and 6C. The results
show that although serum, MAiGn, and bicarbonate all can acti-
vate cAMP synthesis, no synergy was observed between bicar-
bonate and serum or MAiGn in enhancing the cyclase activity
Cell Host & Microbe
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(A) Yeast cells of strains expressing various CYR1 alleles were induced for hyphal growth by serum. Aliquots were harvested at the indicated times for cellular
cAMP assays.
(B) SC5314 yeast cells were broken by bead beating and assayed for conversion of a-32P-ATP to 32P-cAMP in the presence of different concentrations of MAiGn.
(C) Yeast cells of SC5314, cyr1D, and cyr1-9AA were subjected to the same assay as described in (B) except in the presence of 5 mM MAiGn.(Figure 7C). Together, the mechanisms for the synergy of CO2
and MDPs in promoting the hyphal growth are apparently more
complex than simply increasing the cyclase activity of Cyr1p.
Consistently, Davis-Hanna et al. (2008) observed that although
cells expressing the hyperactivated RasG13V exhibit constitutive
filamentous growth, their cellular cAMP levels were 2- to 2.5-fold
lower than wild-type cells, suggesting that the status of hyphal
growth is not always correlated with high cAMP levels.
RAS1 Is Required for Optimal Response to MDPs
Ras1p is thought to be an upstream regulator of Cyr1p (Leberer
et al., 2001) and ras1D/Dmutants are defective in hyphal growth
(Feng et al., 1999; Leberer et al., 2001; Fang and Wang, 2006),
thereby challenging our hypothesis of the Cyr1 LRR domain be-
ing the sensor. We next examined whether RAS1 is required for
the MDP-induced hyphal growth. We found that although the
ras1D/D cells responded poorly to low concentrations of
MDPs, they exhibited significant filamentous growth, even true
hyphal growth in the presence of high concentrations of the in-
ducers. An example is shown in Figure 7D. After a 3 h induction
with 40 mM Mur-L-Ala-D-Glu (I50 = 6 mM, see Figure 2), 40%
of the ras1D/D cells formed true hyphae while the rest were in
pseudohyphal or yeast form. The mutant also exhibited in-
creased filamentous growth in response to greater concentra-
tions of serum. A mutant expressing a version of Cyr1p with
the RA domain deleted (Fang and Wang, 2006) yielded similar
results (data not shown). The data indicate that while lacking
Ras1p greatly reduces the cell’s sensitivity to the hyphal in-
ducers, it does not completely abolish it. Weak filamentous
growth in serum-containing media was also shown in previous
reports (Feng et al., 1999; Leberer et al., 2001). Together with
the well-established Ras association with adenylyl cyclases in
yeast (Toda et al., 1985; Fang and Wang, 2006), we proposethat Ras1p and Cyr1p work as a complex that constitutes part
of a sensor/effector machinery, and their interaction ensures
proper protein folding for optimal ligand sensing and/or subse-
quent allosteric activation of the catalytic domain. Without
Ras1p the system functions partially, thereby requiring strong in-
ducing signals to activate downstream events for hyphal growth.
This model explains our observations above. However, we can-
not rule out the possibility that signal sensing may also occur
upstream of Ras1p.
DISCUSSION
Serum is a strong inducer for the yeast-to-hypha transition in
C. albicans, a well-proven virulence trait. Therefore, identification
and characterization of the inducing entities in serum and under-
standing theirmechanisms of action will impact the development
of therapies for one of the most common infectious diseases. In
this study, we first observed by NMR analysis signs of PGN-like
molecules in chromatographic fractions of serum highly active
for hyphal induction. Later, we confirmed that several purified
and synthetic MDPs indeed exhibited such activity. Strikingly,
some of these molecules are 100- to 1000-fold more potent
than any other compounds documented so far for hyphal induc-
tion in C. albicans. Prompted by current understanding of mech-
anisms for PGN sensing by LRR domains of some PRRs in mam-
mals, we obtained compelling evidence that C. albicans senses
MDPs using the LRR domain of the adenylyl cyclase Cyr1p. De-
leting either the entire or part of the LRR domain or mutating
some of the highly conserved residues in a single repeat abol-
ished the postinduction cAMP spike and blocked hyphal growth.
Moreover, we showed that MDPs can bind to the LRR domain
in vitro and Cyr1p in cell lysates. The importance of our findings
is manifold. First, we reveal a host-associated factor, namelyCell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc. 35
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Peptidoglycan Induces Candida albicans Hyphal GrowthFigure 7. Synergy of MDPs and CO2 and the Role of RAS1 in Hyphal Growth
(A) SC5314 cells were induced for hyphal growth in HBSS containing the indicated concentrations of MAiGn at 37C for 3 hr either in the atmospheric air or in 5%
CO2.
(B) Effects of bicarbonate on cAMP levels. SC5314 cells were induced for hyphal growth in HBSS containing 10 mM sodium bicarbonate or 25% serum at 37C.
Cells were harvested at the indicated times for cellular cAMP assays.
(C) SC5314 yeast cells were lysed by bead beating and assayed for conversion of a-32P-ATP to 32P-cAMP in the absence (control) or presence of various
inducers: SB, 10 mM sodium bicarbonate; M, 5 mM MAiGn; and S, 10% serum filtrate.
(D) SC5314 and ras1D/D (ura+) yeast cells were induced for hyphal growth in HBSS containing Mur-L-Ala-D-Glu (MAGlu) or serum filtrate at the indicated
concentrations and incubated at 37C for 3 hr.PGN-derived molecules that may play a previously unknown yet
potentially important role in C. albicans infections. Second, we
provide key insights into the mechanisms of signal sensing for
C. albicans hyphal growth. Third, our findings suggest that the
recognition of PGNs by the LRR domain may represent an an-
cient mechanism that perhaps first evolved as ameans for fungal36 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.cells to monitor and respond to bacteria. Fourth, our findings
disclose potential targets for developing novel anti-Candida
therapies.
We propose that MDPs act as allosteric regulators of the
Cyr1p cyclase by binding to the LRR domain. This design princi-
ple with both the signal sensor and the catalytic domain in the
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clases to which Cyr1p belongs (Linder and Schultz, 2003). Mem-
bers of this family typically have a C-terminal catalytic domain
and multiple N-terminal domains. These N-terminal domains
play regulatory roles by serving as sensors for various ligands/
signals (Linder and Schultz, 2003). Cyr1p orthologs have been
found in all fungi whose genome sequences are available.
Figure S4 shows the domain organization of adenylyl cyclases
from 30 fungi. These proteins are highly conserved in domain or-
ganization and invariably contain 11–16 LRRs near the center.
However, data on LRR’s role in regulating the cyclase activity
remain strikingly limited. In recent years, it has rapidly become
clear that a key feature of many proteins involved in innate
immunities, such as the Toll-like receptors in animals (Royet
and Dziarski, 2007) and the R proteins in plants (Takken et al.,
2006), is the presence of long LRR domains. Substantial evi-
dence is available strongly supporting the idea that the LRR do-
mains function as sensors for diverse microbial molecules. A
prominent example is the mammalian bacterial sensors Nod1
and Nod2: they bind distinct PGN-motifs, including MNAiGn,
leading to the activation of immune responses (Girardin et al.,
2003a, 2003b; Inohara and Nun˜ez, 2003a; Inohara et al.,
2003b; Philpott and Girardin, 2004). Taken together, the mecha-
nisms for class III adenylyl cyclase regulation and the roles of
LRR domains in recognizing PAMPs are consistent with our find-
ings and support our proposal that the LRR domain of Cyr1p is
a sensor for MDPs. However, we cannot rule out the possibility
that the LRR domain may also sense other hypha-inducing mol-
ecules. Given the conserved roles of the Cyr1p family of adenylyl
cyclases in regulating cellular responses to environmental condi-
tions, it would be interesting to find out whether the role of LRR
domains in signal sensing are ubiquitous in fungi. The fungal LRR
domains shown in Figure S4 share 22% to 94% amino acid iden-
tities and contain different number of repeats with distinct clus-
tering patterns. This feature underlies an enormous structural
diversity, which may play a role in determining the specificity of
signal sensing.
Mammals are not known to be able to synthesize Mur. Then,
where do the Mur-containing molecules in serum come from?
The human intestinal mucosa harbors 1014 of bacteria belong-
ing to 500 species, which produce abundant, structurally
diverse PGN-derived molecules (O’Hara and Shanahan, 2006).
In addition, the intestinal epithelium is the largest microbe-host
interface in the human body where bacteria are constantly sam-
pled and degraded by specialized immune cells (Kelly et al.,
2005). Experiments in rats have shown that PGNs can enter
the circulation system through the intestinal epithelium (Sartor
et al., 1987, 1988). Thus, intestinal bacteria are the most likely
sourceofMur-containingmolecules in serum.BecauseC. albicans
colonize the gastrointestinal track, it should be of high impor-
tance to learn about how C. albicans responds to MDPs in its
natural habitat and how this contributes to its invasion of the
epithelium.
So far, we have only been able to infer the presence ofMDPs in
serum based on the detection of Mur. The inherent high-PGN
heterogeneity of bacterial species together with many possible
ways of PGN degradation by both the producers and the host
is expected to produce a complex repertoire of PGN-derived
molecules. Therefore, it is highly likely that MDPs in serum arepresent in many forms and each at low concentrations.
Compounded with the high chemical complexity of serum and
the unfavorable chromatographic properties of sugars, it is cur-
rently technically challenging to purify each of the PGN-derived
molecules for structural elucidation.
Our findings reveal a mechanism for fungi to sense and react
to bacteria, which have important implications in understanding
the basis of C. albicans infections as well as how other fungal
species respond to environmental signals.
EXPERIMENTAL PROCEDURES
Isolation of the Hypha-Inducing Factors from Bovine Serum
and Human Plasma
Aliquots of bovine serum (Hyclone, Logan, UT) or human plasma (local hospi-
tals) were first passed through a C18 cartridge (Waters Co., Milford, MA) to re-
move highly nonpolar components. Then trifluoroacetic acid (TFA) was slowly
added in by vigorous stirring to a final concentration of 0.1%. The solution was
filtered by using a Centriplus membrane (Millipore, Billerica, MA) with 3 kDa
cutoff. Then, 200 ml of the filtrate was applied to an Amersham Superdex Pep-
tide HR 30/10 gel filtration column (Amersham, Buckinghamshire, UK) for sep-
aration by FPLC (Amersham). Mobile phase was 0.04% TFA in H2O and flow
rate was 0.6 ml/min. Fractions of 0.6 ml were collected and tested for hyphal
induction. The highest activity was eluted at 20–22 min. These fractions were
pooled, lyophilized, and resuspended in 0.04% TFA before reversed-phase
HPLC (Waters) using a PrepNova-PakHR C18 column (7.83 300 mm). Solvent
A was 0.04% TFA in water and B was 0.04% TFA in acetonitrile. A linear gra-
dientwasused: 0–0.5min, 5%Bwith the flow rate increased from0 to 2.0ml/min;
0.5–10 min, 5% B; 10–45 min, 5% to 50% B; 45–50 min, 50%–5% B;
60–60.1 min, 5% B; and the flow rate was reduced from 2.0 to 0 ml/min.
Detection and Quantification of Mur in Serum
Human serum samples were donated by three male and two female healthy
volunteers of 25–30 years of age. To release Mur from PGN, 500 ml of serum
filtrate were lyophilized, resuspended in 4 N HCl, and hydrolyzed at 90C for
3 hr. The hydrolysis product was dried in a Savant Speed Vac and then dis-
solved in 100 ml of 400 mM sodium borate (pH 9.6) with the pH adjusted
to 8.5 with NaOH. To reduce the sugar ring of Mur, 100 ml of borohydride
(20 mg/ml) was added for reaction at RT for 2 hr. Excess borohydride was
destroyed by adjusting pH to 4 with phosphoric acid. Then 400 ml of borate
buffer (400 mM, pH 9.6) was added and the pH adjusted to 8.5 with NaOH.
To dansylate Mur, 12.95 mg of dansylchoride in 600 ml acetone were added
and the reaction incubated at RT overnight. The sample was dried first in
Speed Vac to remove acetone followed by lyophilization and resuspension
in 200 ml of 5% acetonitrile and 0.04% TFA. For control, 5 mg of Mur
(Sigma-Aldrich) in 500 ml H2O were similarly processed. The above processed
samples and standardMur were resolved by HPLC using aWaters SunFire C18
reverse-phase column (4.6 3 150 mm, 3.5 mm) with a UV-VIS detector set
at 204 nm. The flow rate was 0.8 ml/min. Solution A was 0.04%
TFA in H2O, and B was 0.04% TFA in acetonitrile. At 0, 25, 30, 40, and 45
min, the percentage of solution B was 11, 11, 50, 50, and 11, respectively.
The fractions corresponding to the standard dansyl Mur was collected for
mass spectrometry.
Preparation of Bacterial Peptidoglycan
High-purity PGN was prepared by combining previous protocols by Popham
et al. (1996) and Koehl et al. (2004). E. coli was grown in nutrient broth for
24 hr and harvested by centrifugation. The pellet was washed 33 with PBS
before lyophilization. Eight-hundred milligrams of the lyophilized cells were
resuspended in 15 ml of extraction buffer containing 50 mM Tris-HCl (pH
8.0), 4% SDS (w/v), 30 mM DTT, and 2 mM EDTA; incubated in a 100C water
bath for 20 min; and then shifted to 37C for 40 min. The sample was centri-
fuged at 13,000 g for 30 min, and the pellet was resuspended in 37C distilled
water. This wash was done 53 to remove SDS before resuspending the pellet
in 6 ml of 50 mM Tris-HCl (pH 7.0) containing 12 mg pronase and incubated at
37C for 1 hr. Pronase was inactivated by heating at 60C for 90 min. TheCell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc. 37
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pended in 50 mM Tris-HCl (pH 7.0) containing 4% SDS (w/v), 30 mM DTT,
and 2 mM EDTA, and incubated in a 100C water bath for 20 min. The sample
was then washed 73 in 37C distilled water. After each wash, PGN was spun
down at 160,000 g for 4 hr. S. aureus PGNwas purchased from Sigma-Aldrich.
C. albicans Growth Conditions
The strains were routinely grown in YPD (2% yeast extract, 1% bactopeptone,
and 2% glucose) or GMM (2% glucose, 6.79 g/l yeast nitrogen base without
amino acid). For hyphal growth, yeast was incubated at 37C in GMM or
HBSS containing 10% serum or various amounts of hypha-inducing com-
pounds. HBSS contains 80 g NaCl, 4 g KCl, 10 g glucose, 600 mg KH2PO4,
and 475 g Na2HPO4 (pH7.2) in 1 L of H2O. For hyphal growth on solid media,
serum or a compound was added tomelted solid media at 50C. For yeast cul-
ture, cells were grown at 30C. G1 cells were obtained by elutriation using
a Beckman (Fullerton, CA) JE elutriator.
CYR1 Expression and LRR Domain-Deletion Constructs
To generate the plasmid for expressing CYR1, the ORF with 550 bp promoter
and 630 bp 30 untranslated region was PCR amplified and cloned into CIp10
(Murad et al., 2000). Restriction sites were added in the PCR primers for clon-
ing. This plasmid was also used for introducing LRR domain mutants. For
domain deletion, the CYR1 regions flanking the segment to be deleted were
PCR amplified and recloned into CIp10 without disrupting the reading frame.
The QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA)
was used to create point mutations. Each of the CYR1 constructs was linear-
ized at a unique MluI site in the promoter and integrated at the CYR1 locus in
the cyr1D mutant.
Intracellular cAMP Assay
This assay followed the methods of Rocha et al. (2001) and Jung and Stateva
(2003) with modifications. For hyphal induction, yeast cells were grown in YPD
at 30C to OD600 = 1.5, harvested by centrifugation, washed 23 with HBSS,
and then resuspended to 1.253 108 cells/ml in HBSS containing 25% serum.
Cells were incubated at 37C with shaking, and 20 ml aliquots were harvested
at intervals. Cells were immediately frozen in liquid nitrogen. cAMP was ex-
tracted as described (Jung and Stateva, 2003) and quantitated using the EIA
system-cAMP immunoassay (Amersham).
Adenylyl Cyclase Activity Assay
The assay is as described by Soloman et al. (1974) using sequential chroma-
tography on Dowex cation exchange resin columns (The Dow Chemical Com-
pany, Midland, MI) and aluminum oxide. Briefly, 1 3 1010 late log-phase cells
were harvested by centrifugation and resuspended in ice-cold 25 mM Tri-HCl
(pH 7.5). After two washes, the cells were resuspended in 1 ml of the same
buffer in a 2 ml screw-cap tube and mixed with 0.4 ml of acid-washed glass
beads (Sigma-Aldrich). Cells were lysed in a Mini-Beadbeater (Biospec Prod-
ucts, Inc., Bartlesville, OK) for six rounds of 2 min beating at 4C with cooling
on ice between rounds. Then 100 ml of the lysate was mixed with 100 ml of re-
action mix containing 25 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 20 mM creatine
phosphate, 100 U/ml creatine phosphokinase, 1 mM cAMP, and 3 mCi of
a-32P-ATP. The reaction was incubated at 37C for 10min and then terminated
by adding 200 ml of 2% SDS. Then, the mixture was centrifuged at 14,000 g for
10 min at 4C. 32P-cAMP from 200 ml of the supernatant was isolated for
scintillation counting.
Synthesis of Biotin-MNAiGn and 3H-MNAiGn
See Supplemental Data.
3H-MNAiGn Uptake Assay
Overnight yeast culture was inoculated into fresh YPD at 1:10 dilution and
grown at 30C to OD600 = 1.5. Cells were harvested by centrifugation, washed
33 with HBBS, and then resuspended in HBBS at 108 cells/ml. 3H -MNAiGn
was added to 2 ml cultures at different concentrations and incubated at
37C. Cells were harvested at intervals and washed 53 with cold HBBS. 3H
was counted by a scintillation counter.38 Cell Host & Microbe 4, 28–39, July 17, 2008 ª2008 Elsevier Inc.SUPPLEMENTAL DATA
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